Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2OTHER_GOV 1

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 2876Carcinoma, Non-Small-Cell Lung 2430Breast Neoplasms 2070Colorectal Neoplasms 1248Neoplasm Metastasis 1233Prostatic Neoplasms 1083Melanoma 973Multiple Myeloma 963Ovarian Neoplasms 904Recurrence 851Leukemia, Myeloid, Acute 809Lung Neoplasms 759Pancreatic Neoplasms 753Lymphoma, Non-Hodgkin 727Lymphoma 660Stomach Neoplasms 624Carcinoma, Hepatocellular 567Carcinoma, Renal Cell 547Squamous Cell Carcinoma of Head and Neck 529Leukemia, Lymphocytic, Chronic, B-Cell 493Lymphoma, Follicular 469Head and Neck Neoplasms 452Glioblastoma 436Advanced Solid Tumors 433Small Cell Lung Carcinoma 411Triple Negative Breast Neoplasms 410Lymphoma, Large B-Cell, Diffuse 398Leukemia 394Uterine Cervical Neoplasms 369Advanced Solid Tumor 351

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Safety Issues × Clear all
NCT05142592 2025-09-24

Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors

Nanjing Immunophage Biotech Co., Ltd

Phase 1/2 Recruiting
196 enrolled

Safety Issues

NCT05580172 2022-10-17

Phase 1 Study of Oral RH324 in Advanced Non-Small Cell Lung Cancer

ReHeva Biosciences,Inc.

Phase 1 Unknown
6 enrolled

Safety Issues

Data powered by HemOnc (CC BY 4.0) Colophon âš¡